Editorial: The Role of Lipids in the Pathogenesis of Parkinson's Disease

Editorial: The Role of Lipids in the Pathogenesis of Parkinson's Disease

Bibliographic Details
Main Authors:	Veerle Baekelandt, Evy Lobbestael, Helena Xicoy, Gerard J. M. Martens
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-03-01
Series:	Frontiers in Neuroscience
Subjects:	oxidative stress lipids neuroinflammation Parkinson's disease Parkinson's disease models α-synuclein
Online Access:	https://www.frontiersin.org/article/10.3389/fnins.2020.00250/full

Similar Items

The Role of Lipids in Parkinson’s Disease
by: Helena Xicoy, et al.
Published: (2019-01-01)

Lipids as Trans-Acting Effectors for α-Synuclein in the Pathogenesis of Parkinson’s Disease
by: Kensuke Ikenaka, et al.
Published: (2019-07-01)

Multiple-Hit Hypothesis in Parkinson’s Disease: LRRK2 and Inflammation
by: Diego Cabezudo, et al.
Published: (2020-04-01)

α-Synuclein and Noradrenergic Modulation of Immune Cells in Parkinson’s Disease Pathogenesis
by: Laura M. Butkovich, et al.
Published: (2018-09-01)

Immunoregulation of microglial polarization: an unrecognized physiological function of α-synuclein
by: Na Li, et al.
Published: (2020-09-01)

Dysregulated Lipid Metabolism and Its Role in α-Synucleinopathy in Parkinson’s Disease
by: Irina Alecu, et al.
Published: (2019-04-01)

ATP13A2 Regulates Cellular α-Synuclein Multimerization, Membrane Association, and Externalization
by: Jianmin Si, et al.
Published: (2021-03-01)

T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson’s disease
by: Meena S. Subbarayan, et al.
Published: (2020-08-01)

Corynoxine Protects Dopaminergic Neurons Through Inducing Autophagy and Diminishing Neuroinflammation in Rotenone-Induced Animal Models of Parkinson’s Disease
by: Leilei Chen, et al.
Published: (2021-04-01)

Transcriptome analysis of LRRK2 knock-out microglia cells reveals alterations of inflammatory- and oxidative stress-related pathways upon treatment with α-synuclein fibrils
by: Isabella Russo, et al.
Published: (2019-09-01)

Neuron-Astrocyte Interactions in Parkinson’s Disease
by: Ikuko Miyazaki, et al.
Published: (2020-12-01)

Autophagic- and Lysosomal-Related Biomarkers for Parkinson’s Disease: Lights and Shadows
by: Helena Xicoy, et al.
Published: (2019-10-01)

Interaction of Alpha-Synuclein With Lipids: Mitochondrial Cardiolipin as a Critical Player in the Pathogenesis of Parkinson’s Disease
by: Valentina Gilmozzi, et al.
Published: (2020-10-01)

Lymphocyte-activation Gene 3 (LAG3) Protein as a Possible Therapeutic Target for Parkinson’s Disease: Molecular Mechanisms Connecting Neuroinflammation to α-synuclein Spreading Pathology
by: Efthalia Angelopoulou, et al.
Published: (2020-04-01)

The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?
by: Tianfang Jiang, et al.
Published: (2018-09-01)

Ncx3-Induced Mitochondrial Dysfunction in Midbrain Leads to Neuroinflammation in Striatum of A53t-α-Synuclein Transgenic Old Mice
by: Rossana Di Martino, et al.
Published: (2021-07-01)

Corrigendum: The Challenge of the Pathogenesis of Parkinson's Disease: Is Autoimmunity the Culprit?
by: Tianfang Jiang, et al.
Published: (2019-10-01)

Editorial: Biomarkers and Pathogenesis of Alpha-Synuclein in Parkinson's Disease
by: Puyu Li, et al.
Published: (2021-10-01)

Chronic nigral neuromodulation aggravates behavioral deficits and synaptic changes in an α-synuclein based rat model for Parkinson’s disease
by: Teresa Torre-Muruzabal, et al.
Published: (2019-10-01)

Gut Inflammation in Association With Pathogenesis of Parkinson’s Disease
by: Qian-Qian Chen, et al.
Published: (2019-09-01)

Targeting Microglial α-Synuclein/TLRs/NF-kappaB/NLRP3 Inflammasome Axis in Parkinson’s Disease
by: Yunna Li, et al.
Published: (2021-10-01)

Novel Immunotherapeutic Approaches to Target Alpha-Synuclein and Related Neuroinflammation in Parkinson’s Disease
by: Maria Angela Samis Zella, et al.
Published: (2019-01-01)

The Links between Parkinson’s Disease and Cancer
by: Maria Ejma, et al.
Published: (2020-10-01)

The role of Ca2+ signaling in Parkinson's disease
by: Sofia V. Zaichick, et al.
Published: (2017-05-01)

Autoimmunity in Parkinson's Disease: The Role of α-Synuclein-Specific T Cells
by: Francesca Garretti, et al.
Published: (2019-02-01)

Alpha-Synuclein and Lipids: The Elephant in the Room?
by: Alessia Sarchione, et al.
Published: (2021-09-01)

Modeling Parkinson’s Disease Neuropathology and Symptoms by Intranigral Inoculation of Preformed Human α-Synuclein Oligomers
by: Laura Boi, et al.
Published: (2020-11-01)

Macroautophagy in sporadic and the genetic form of Parkinson's disease with the A53T α-synuclein mutation
by: Huang Yue, et al.
Published: (2012-01-01)

Co-aggregation of pro-inflammatory S100A9 with α-synuclein in Parkinson’s disease: ex vivo and in vitro studies
by: Istvan Horvath, et al.
Published: (2018-06-01)

Editorial: Protein Degradation Pathways in Parkinson's Disease and Neurodegeneration
by: Mattia Volta, et al.
Published: (2020-07-01)

Silymarin promotes longevity and alleviates Parkinson’s associated pathologies in Caenorhabditis elegans
by: Swati Srivastava, et al.
Published: (2017-04-01)

Superoxide dismutase overexpression protects dopaminergic neurons in a Drosophila model of Parkinson's disease
by: Jose A. Botella, et al.
Published: (2008-04-01)

Erythrocytic α-Synuclein as a potential biomarker for Parkinson’s disease
by: Chen Tian, et al.
Published: (2019-05-01)

Mini-review on initiatives to interfere with the propagation and clearance of alpha-synuclein in Parkinson’s disease
by: Daniel Kam Yin Chan, et al.
Published: (2017-12-01)

FcγRIIB mediates the inhibitory effect of aggregated α-synuclein on microglial phagocytosis
by: Yu Ree Choi, et al.
Published: (2015-11-01)

Interaction between Neuromelanin and Alpha-Synuclein in Parkinson’s Disease
by: Shengli Xu, et al.
Published: (2015-06-01)

The Roles of Post-translational Modifications on α-Synuclein in the Pathogenesis of Parkinson’s Diseases
by: Jiaming Zhang, et al.
Published: (2019-04-01)

Papaverine inhibits α-synuclein aggregation by modulating neuroinflammation and matrix metalloproteinase-3 expression in the subacute MPTP/P mouse model of Parkinson’s disease
by: Yea-Hyun Leem, et al.
Published: (2020-10-01)

Impaired dopamine metabolism in Parkinson’s disease pathogenesis
by: Anna Masato, et al.
Published: (2019-08-01)

Regulation and targeting of enzymes mediating Parkinson’s disease pathogenesis: focus on Parkinson’s disease kinases, GTPases and ATPases
by: Jean-Marc eTaymans, et al.
Published: (2014-07-01)

Cannot write session to /tmp/vufind_sessions/sess_bf2ialg1qkmo1kbloo27ieicao